- Home
- Services
- north korea
- patients enrolled
Show results for
Refine by
Patients Enrolled Services Available In North Korea
7 services found
by:Verana Health based inSan Francisco, CAMBODIA
From protocol development and clinical trial design to site selection and identifying potential participants*, we help speed patient enrollment to help you meet your recruitment goals. Find out how Verana Health can support your next rare disease, site-based, or multi-disciplinary ...
Manufactured by:ACS Diagnostics based inIrvine, CALIFORNIA (USA)
Unlike other ECG monitoring companies that only allow you to see the ECG around the arrhythmia, ACS Diagnostics offers full-disclosure of every beat of every day for every enrolled patient. We want you, the doctor, to be the final decision maker on your patient’s health. ACSD is focused on the continued continuity of care for each of our ...
by:Clinigen Clinical Supplies Management based inBurton-on-Trent, UNITED KINGDOM
We recognise the packaging and labelling obstacles that you may face during your clinical trials - from time constraints to study changes that cause re-work and waste. On average, 50% of all clinical supplies that are packaged and labelled are never ...
Manufactured by:ACS Diagnostics based inIrvine, CALIFORNIA (USA)
We offer RPM (Remote Patient Monitoring). Today’s new generation of remote ECG monitoring technologies now enables 24/7 data recording. Some systems also enable near-real-time, wireless data analysis, which offers advantages over the old process of reviewing recorded data after a patient turns in a device. If your patient is symptomatic, why wait to see results? Order a RPM device directly ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Graft Versus Host Disease (GvHD) is a potentially lethal complication of hematopoietic cell transplantation (HCT) from a donor. When a patient receives a donor’s stem cells, the transplanted cells may identify the patient’s body as foreign and attack it. The chronic form of GvHD occurs at least 100 days following the transplantation. The GvHD market is predicted to exceed $500 million ...
by:Ascendia Pharmaceutical Solutions based inNorth Brunswick, NEW JERSEY (USA)
In the intricate landscape of biopharmaceuticals, development timing is a critical factor that can significantly impact the success or failure of a drug. Saving time can mean the difference between being first to market for a new drug class or a first-to-file ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...